Overview

Assessing the Value of Neurological Imaging in RRMS to Best Evaluate Neurodegeneration and Patient Outcomes

Morning Satellite Symposium

Registration is closed for this activity.

Format

Live In-person Meeting

Time to Complete

1.50 hr(s).

Date

Saturday, February 25, 2017 06:45 AM ET

Location

Orlando, FL

This satellite symposium will include 3 faculty members in an interactive discussion of neurological imaging and its value and role in DMT selection, prognosis, and outcomes in RRMS as well as a review of emerging agents and associated clinical data.

This program is not part of the official ACTRIMS Forum 2017. Separate conference registration is required. No additional fee is required to attend this symposium.

This educational activity is designed for physicians, pharmacists, nurses, scientists, and researchers examining the advances in research and treatment of MS on the care of patients.

MS is a rapidly advancing field, not only in terms of the evolution of disease-modifying therapies, but also with respect to neurobiological advancements in myelin repair. Additionally, refinement is being made to existing MRI measures to provide clinicians with clinically practical approaches to the management of MS. Clinicians treating MS patients may not be familiar with these advancements and would benefit from expert recommendations, guidance, and training to understand how MRI may be used to assess the risks and benefits of MS therapies, and track disease progression, in order to optimize disease management.

Upon completion of this activity, participants will be able to:

Assess if and how available and emerging MS therapies impact neurodegeneration
Review how MRI can be used to assess brain atrophy to identify patients with MS at the highest risk for decline
Explain how brain volume loss may be another outcome measure for assessing disease progression and disability in patients with MS

Omni Orlando Resort at Champions Gate
1500 Masters Boulevard
Orlando, FL 33896 USA
Click here to view location map
Comment: Osceola Ballroom C & D

Learn about topics including:
• Current, clinical applications of MRI in MS
• Brain atrophy in MS
• Neuroprotection and repair in MS

Sponsored by the Academy for Continued Healthcare Learning

This activity is supported by an educational grant from Teva Pharmaceuticals

Patricia Coyle, MD
Professor and Vice Chair (Clinical Affairs)
Director, MS Comprehensive Care
Department of Neurology
Stony Brook University Medical Center
Stony Brook, NY

Edward J. Fox, MD, PhD

Clinical Associate Professor

Department of Neurology

Dell Medical School, University of Texas at Austin

Director, MS Clinic of Central Texas

Central Texas Neurology Consultants

Round Rock, TX

David Li, MD, FRCPC

Professor Emeritus of Radiology and Associate Member in Neurology
Department of Radiology and Medicine (Neurology)

Director Emeritus, MS/MRI Research Group

University of British Columbia

Vancouver, BC

Guidelines require that participants in CME/CE activities be made aware of all financial relationships that may be perceived as affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose relevant financial relationships and that conflicts of interest are resolved before the CME/CE activity occurs. Complete information will be provided to participants prior to the start of the educational activity.

To receive credit, participants are required to complete the evaluation form and submit on-site. A certificate will be emailed to participants within 6 weeks of receipt of the form. There is no fee to participate in the activity or for the generation of the certificate.

Inquiries may be directed to ACHL at (877) 444-8435, ext. 228.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Multiple Sclerosis Association of America (MSAA). ACHL is accredited by the ACCME to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Karen Catino
kcatino@achlcme.org

Overview

Assessing the Value of Neurological Imaging in RRMS to Best Evaluate Neurodegeneration and Patient Outcomes

Program Description

Intended Audience

Activity Purpose

Learning Objectives

Activity Location

Meeting Schedule

Provider Information

Supporter Information

Faculty

Disclaimer

Method of Participation

Accreditation and Credit Designation

Program Manager

Related Activities